MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 45 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,603 | -60.5% | 19,600 | 0.0% | 0.01% | -53.3% |
| Q2 2023 | $29,400 | -12.8% | 19,600 | 0.0% | 0.02% | -6.2% |
| Q1 2023 | $33,712 | +146473.9% | 19,600 | 0.0% | 0.02% | +23.1% |
| Q4 2022 | $23 | -100.0% | 19,600 | 0.0% | 0.01% | -59.4% |
| Q3 2022 | $51,000 | +18.6% | 19,600 | 0.0% | 0.03% | +10.3% |
| Q2 2022 | $43,000 | -52.7% | 19,600 | 0.0% | 0.03% | -65.9% |
| Q1 2022 | $91,000 | -23.5% | 19,600 | 0.0% | 0.08% | +10.4% |
| Q4 2021 | $119,000 | +46.9% | 19,600 | +74.4% | 0.08% | +28.3% |
| Q3 2021 | $81,000 | +14.1% | 11,240 | 0.0% | 0.06% | +27.7% |
| Q2 2021 | $71,000 | – | 11,240 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 139,986 | $365,000 | 0.08% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $45,000 | 0.04% |
| Bridgecreek Investment Management, LLC | 65,000 | $170,000 | 0.04% |
| Corundum Group, Inc. | 19,600 | $51,000 | 0.03% |
| Aaron Wealth Advisors LLC | 50,000 | $131,000 | 0.02% |
| M Holdings Securities, Inc. | 70,909 | $185,000 | 0.02% |
| Cambria Investment Management, L.P. | 65,398 | $171,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $39,000 | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 638,580 | $1,667,000 | 0.00% |
| Western Wealth Management, LLC | 25,050 | $71,000 | 0.00% |